ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib
Open Access
- 21 September 2006
- journal article
- Published by Wiley in Cancer Science
- Vol. 97 (12) , 1404-1409
Abstract
ZD6474 (Zactima, AstraZeneca, Macclesfield, UK) is an orally available, small‐molecule inhibitor of vascular endothelial growth factor receptor‐2 and epidermal growth factor receptor tyrosine kinases, with additional activity versus rearranged during transfection (RET). This study explored the effect of ZD6474 in gastrointestinal stromal tumor‐T1 (GIST‐T1) cells that possess a gain of function mutation in exon 11 of the c‐KIT gene. ZD6474 induced growth arrest and apoptosis of GIST‐T1 cells in association with blockade of c‐Kit and its downstream effectors, including Akt and extracellular signal‐regulated kinase (ERK). ZD6474 treatment also blocked the mammalian target of rapamycin (mTOR), which lies downstream of Akt and ERK. Interestingly, when ZD6474 was combined with sunitinib (SU11248; Sutent, Pfizer, Kalamazoo, MI, USA), a class III and V receptor tyrosine kinase inhibitor, the ZD6474‐mediated growth inhibition was potentiated in association with further down‐regulation of the mTOR targets p‐p70S6K and p‐4E‐BP‐1. The combination of ZD6474 and sunitinib should be investigated further. (Cancer Sci 2006; 97: 1404–1409)Keywords
This publication has 28 references indexed in Scilit:
- Effect of SU11248 on gastrointestinal stromal tumor‐T1 cells: Enhancement of growth inhibition via inhibition of 3‐kinase/Akt/mammalian target of rapamycin signalingCancer Science, 2006
- Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)Biochemical Journal, 2005
- Phosphorylation and Functional Inactivation of TSC2 by ErkCell, 2005
- Imatinib and gastrointestinal stromal tumors: Where do we go from here?Molecular Cancer Therapeutics, 2005
- Upstream and downstream of mTORGenes & Development, 2004
- Lost in translationCancer Cell, 2004
- CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)Cancer Cell, 2002
- Conventional and Molecular Cytogenetic Characterization of a New Human Cell Line, GIST-T1, Established from Gastrointestinal Stromal TumorLaboratory Investigation, 2002
- KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in SizeThe American Journal of Pathology, 2002
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998